Labcorp Launches Next Generation of Global Trial Connect to Streamline Clinical Trial Operations
核心洞察
Labcorp (搜索) announced enhancements to its Global Trial Connect (搜索)™ platform, introducing new capabilities across the Labcorp Sponsor™ and Labcorp Investigator™ portal experiences to improve study visibility and simplify workflows.
The redesigned platform was informed by feedback from more than 80 sponsors and 100 investigator sites worldwide, with embedded in-portal kit ordering reducing manual data entry by 75%.
New features include a unified Study Oversight Dashboard, a Report Wizard, and end-to-end sample tracking, helping sponsors and sites make faster, more informed decisions.
Labcorp (搜索) (NYSE: LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the digital experience of Labcorp Global Trial Connect (搜索)™, the company's portfolio of clinical trial services, data and technology that enhances and accelerates delivery. The newly redesigned platform introduces new capabilities across the Labcorp Sponsor™ and Labcorp Investigator™ portal experiences of Global Trial Connect, providing greater visibility across studies, simplifying workflows and helping sponsors and investigator sites make faster, more informed decisions.
"As clinical trials become increasingly complex, sponsors and investigator sites need technology that helps them work more effectively," said Brian Caveney, M.D., EVP and president, Biopharma Laboratory Services and chief medical and scientific officer, Labcorp (搜索). "The latest enhancements to Global Trial Connect (搜索) make it easier to access insights, manage study activities and navigate trial complexity with confidence, allowing customers to focus less on operational tasks and more on advancing research and supporting patients."
Designed with Customers, for Customers
Guided by input from more than 80 sponsors and 100 investigator sites worldwide, the latest enhancements to Global Trial Connect (搜索) were informed by extensive customer feedback, product testing and direct input. Key updates include a more intuitive user experience with simplified navigation and role-based customization, as well as streamlined study management with integrated tools for study oversight, reporting and supply tracking.
The platform introduces embedded in-portal kit ordering that reduces manual data entry by 75% while optimizing inventory oversight and management. It also provides greater visibility into study performance through a unified Study Oversight Dashboard that brings together study, site, sample and supply insights in a single view. Additionally, a new Report Wizard simplifies report creation by guiding users through building and customizing reports to meet their needs, while enhanced sample visibility enables end-to-end tracking across the sample lifecycle.
Advancing the Future of Clinical Trial Delivery
These enhancements represent the latest milestone in Labcorp (搜索)'s ongoing investment in digital solutions across its Biopharma Laboratory Services business, helping sponsors and investigator sites deliver high-quality clinical trials more efficiently. Through continued collaboration with customers, Labcorp will further evolve Global Trial Connect (搜索) to address emerging industry challenges and provide a more connected experience across the clinical trial lifecycle.
Labcorp (搜索)'s nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025, and performed more than 750 million tests for patients around the world.